a developer of gene therapy treatments
Industry Biotechnology
A.I.dvisor indicates that over the last year, RGNX has been loosely correlated with BEAM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if RGNX jumps, then BEAM could also see price increases.
Ticker / NAME | Correlation To RGNX | 1D Price Change % | ||
---|---|---|---|---|
RGNX | 100% | +1.72% | ||
BEAM - RGNX | 47% Loosely correlated | -1.57% | ||
PRTA - RGNX | 45% Loosely correlated | -0.75% | ||
DNLI - RGNX | 45% Loosely correlated | -0.87% | ||
CRSP - RGNX | 44% Loosely correlated | -1.85% | ||
EDIT - RGNX | 43% Loosely correlated | -3.58% | ||
More |
Ticker / NAME | Correlation To RGNX | 1D Price Change % |
---|---|---|
RGNX | 100% | +1.72% |
drugs theme (254 stocks) | 46% Loosely correlated | -1.72% |
treatment theme (56 stocks) | 41% Loosely correlated | -1.12% |
gene therapy theme (12 stocks) | 34% Loosely correlated | -4.27% |
biotechnology theme (238 stocks) | 34% Loosely correlated | -1.80% |